Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion type Assertion NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_head.
- NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion description "[This identification of a cluster of four IFNGR2 variants strongly associated with fibrosis progression in chronic HCV infection underlines the role of IFNgamma in the development of liver fibrosis that may pave the way for new treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_provenance.
- NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion evidence source_evidence_literature NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_provenance.
- NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion SIO_000772 20587546 NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_provenance.
- NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion wasDerivedFrom gad-20150221 NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_provenance.
- NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_assertion wasGeneratedBy ECO_0000203 NP148949.RAO9oGUssVfdo6y5Yl5dbeRiCB-kw-h16WNVUiTyOFoLk130_provenance.